358 related articles for article (PubMed ID: 25091696)
1. A joint analysis of metabolomics and genetics of breast cancer.
Tang X; Lin CC; Spasojevic I; Iversen ES; Chi JT; Marks JR
Breast Cancer Res; 2014 Aug; 16(4):415. PubMed ID: 25091696
[TBL] [Abstract][Full Text] [Related]
2. Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.
Budczies J; Brockmöller SF; Müller BM; Barupal DK; Richter-Ehrenstein C; Kleine-Tebbe A; Griffin JL; Orešič M; Dietel M; Denkert C; Fiehn O
J Proteomics; 2013 Dec; 94():279-88. PubMed ID: 24125731
[TBL] [Abstract][Full Text] [Related]
3. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C; Benz CC
Breast Cancer Res; 2008; 10(4):R61. PubMed ID: 18631401
[TBL] [Abstract][Full Text] [Related]
4. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
5. Glutamate enrichment as new diagnostic opportunity in breast cancer.
Budczies J; Pfitzner BM; Györffy B; Winzer KJ; Radke C; Dietel M; Fiehn O; Denkert C
Int J Cancer; 2015 Apr; 136(7):1619-28. PubMed ID: 25155347
[TBL] [Abstract][Full Text] [Related]
6. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Osborne JR; Port E; Gonen M; Doane A; Yeung H; Gerald W; Cook JB; Larson S
J Nucl Med; 2010 Apr; 51(4):543-50. PubMed ID: 20237034
[TBL] [Abstract][Full Text] [Related]
8. Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome.
Budczies J; Denkert C
Recent Results Cancer Res; 2016; 207():157-75. PubMed ID: 27557538
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer.
Alakwaa FM; Savelieff MG
J Proteome Res; 2020 Jul; 19(7):2879-2889. PubMed ID: 31886666
[TBL] [Abstract][Full Text] [Related]
10. Metabolic characterization of triple negative breast cancer.
Cao MD; Lamichhane S; Lundgren S; Bofin A; Fjøsne H; Giskeødegård GF; Bathen TF
BMC Cancer; 2014 Dec; 14():941. PubMed ID: 25495193
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Haricharan S; Bainbridge MN; Scheet P; Brown PH
Breast Cancer Res Treat; 2014 Jul; 146(1):211-20. PubMed ID: 24839032
[TBL] [Abstract][Full Text] [Related]
12. Ligand-binding Domain-activating Mutations of ESR1 Rewire Cellular Metabolism of Breast Cancer Cells.
Zinger L; Merenbakh-Lamin K; Klein A; Elazar A; Journo S; Boldes T; Pasmanik-Chor M; Spitzer A; Rubinek T; Wolf I
Clin Cancer Res; 2019 May; 25(9):2900-2914. PubMed ID: 30733228
[TBL] [Abstract][Full Text] [Related]
13. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
[TBL] [Abstract][Full Text] [Related]
14. Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
Sun X; Stewart DA; Sandhu R; Kirk EL; Pathmasiri WW; McRitchie SL; Clark RF; Troester MA; Sumner SJ
PLoS One; 2018; 13(4):e0193792. PubMed ID: 29668675
[TBL] [Abstract][Full Text] [Related]
15. Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling.
Brockmöller SF; Bucher E; Müller BM; Budczies J; Hilvo M; Griffin JL; Orešič M; Kallioniemi O; Iljin K; Loibl S; Darb-Esfahani S; Sinn BV; Klauschen F; Prinzler J; Bangemann N; Ismaeel F; Fiehn O; Dietel M; Denkert C
J Proteome Res; 2012 Feb; 11(2):850-60. PubMed ID: 22070544
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer.
Brauer HA; Makowski L; Hoadley KA; Casbas-Hernandez P; Lang LJ; Romàn-Pèrez E; D'Arcy M; Freemerman AJ; Perou CM; Troester MA
Clin Cancer Res; 2013 Feb; 19(3):571-85. PubMed ID: 23236214
[TBL] [Abstract][Full Text] [Related]
17. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
Shen M; Xu M; Zhong F; Crist MC; Prior AB; Yang K; Allaire DM; Choueiry F; Zhu J; Shi H
Cells; 2021 Feb; 10(2):. PubMed ID: 33672651
[TBL] [Abstract][Full Text] [Related]
18. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
19. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
Moestue SA; Borgan E; Huuse EM; Lindholm EM; Sitter B; Børresen-Dale AL; Engebraaten O; Maelandsmo GM; Gribbestad IS
BMC Cancer; 2010 Aug; 10():433. PubMed ID: 20716336
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
